Boston Scientific (BSX) Total Debt Growth (3y) (2012 - 2026)
Boston Scientific (BSX) Total Debt Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -13.48% |
| 10 | Zimmer Biomet Holdings | 19.29 Bn | 18.88 Bn | 1.54 Bn | 9.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.72% |
| Mar 31, 2026 | 6.99% |
| Dec 31, 2025 | 51.40% |
| Sep 30, 2025 | 10.56% |
| Jun 30, 2025 | -52.20% |
| Mar 31, 2025 | 47.66% |
| Dec 31, 2024 | 5.83% |
| Sep 30, 2024 | 6.21% |
| Jun 30, 2024 | 5.09% |
| Mar 31, 2024 | 5.30% |
| Dec 31, 2023 | -0.15% |
| Sep 30, 2023 | 474.22% |
| Jun 30, 2023 | 556.47% |
| Mar 31, 2023 | 666.45% |
| Dec 31, 2022 | 20.87% |
| Sep 30, 2022 | -7.62% |
| Jun 30, 2022 | -2.03% |
| Mar 31, 2022 | -27.52% |
| Dec 31, 2021 | 49.68% |
| Sep 30, 2021 | 11.09% |